Tagged sma
Press Release
Enhanced Profiles Drive BlackRock, Invesco and Boutique Managers to The Wealth Advisor's New Model Portfolio Selection Guide
Segmenting "software-focused" strategist coverage from the TAMP platforms creates space for innovative portfolios to shine in the giants' trillion-dollar shadow Read More
Press Release
Introducing TAM's Newest 'PULSE'ating SMA Product
TAM's products are engineered to combat the low yield, low growth, high volatility challenges facing today's investors. We strive to educate our clients on current market risks and why portfolio shifts in stance are occurring. Read More
Press Release
Families of SMA and Nationwide Children's Hospital Announce Multi-Million Dollar Award from NINDS
Nationwide Children's Hospital and Families of Spinal Muscular Atrophy announce the award of a multi-million dollar cooperative agreement from the NINDS to advance a gene therapy development program for Spinal Muscular Atrophy. Read More
Press Release
ClarySolar Continues To Grow, Becomes An Exclusive Member Of Inc.500 List
ClarySolar: the San Diego Based solar design and installation firm joined the elite group of the top 500 private companies in the US. The Inc. Magazine in its recent publication ranked ClarySolar 295th on the "Inc.500" list in 2012. Read More
Press Release
Families of SMA Announces $1.4 Million Planned for Next Round of Spinal Muscular Atrophy Research Funding
Families of Spinal Muscular Atrophy (FSMA) is dedicated to creating a treatment and cure for Spinal Muscular Atrophy (SMA) by funding and advancing a comprehensive research program Read More
Press Release
Jacob Isaac Rappoport Foundation Aims for Million Dollar Milestone Supporting SMA Research
With the 9th Annual Jacob's Run, Walk & Roll Event to be held on April 1st, The Jacob Isaac Rappoport Foundation is aiming to reach the milestone of raising $1,000,000 for Spinal Muscular Atrophy (SMA) Research Read More
Press Release
Isis Pharmaceuticals Initiates Phase 1 Clinical Study in Patients with Spinal Muscular Atrophy.
Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 study of ISIS-SMNRx in patients with spinal muscular atrophy (SMA). Isis is developing ISIS-SMNRx as a potential treatment for all types of SMA. Read More
Press Release
Families of Spinal Muscular Atrophy Awards 7 New Basic Research Grants for $745,000.
Awards will help develop new approaches for SMA therapies. These new awards encompass $745,000 for the basic research portion of the $3 Million in new research funding that FSMA announced earlier this year. Read More
Press Release
Families of Spinal Muscular Atrophy Awards $3 Million in New SMA Research Funding
The new funding awards will be allocated into three distinct research areas: 1)Basic Research to understand the disease, 2)Drug Discovery to develop new SMA therapies, and 3)Clinical Research to provide the means to test new drugs effectively. Read More
Press Release
Hundreds Of Children And Adults Will Come Together At The South Country Regional Park In Boca Raton For Jacob's Run, Walk & Roll To Cure SMA
Boynton Beach residents Shaina and Adi Rappoport have served as the event organizers since 2002 when their son, Jacob, passed way from SMA (Spinal Muscular Atrophy) related complications. Jacob was nine months old. Read More
Press Release
Families of Spinal Muscular Atrophy Evaluating Six New Drug Discovery Programs for New Funding in 2011
In response to our October Request for Proposals (RFP) for new drug programs to develop therapies for Spinal Muscular Atrophy we received nine Letters of Intent for potential programs. Read More
Press Release
MDA Invests $1.4 Million to Help Advance the Families of SMA Quinazoline Drug Program for Spinal Muscular Atrophy at Repligen Corporation.
The MDA has committed to invest funds in the FSMA Quinazoline Program at Repligen Corporation to assist in advancing the program to an IND filing with the FDA. Read More
Press Release
Families of Spinal Muscular Atrophy Launches Next Phase of Drug Development Efforts for SMA
Families of SMA announces Request for Proposals (RFP) for new drug programs to develop therapies for Spinal Muscular Atrophy. FSMA is aiming to fund two new preclinical drug development programs in 2011, with more to follow. Read More
Press Release
Disabled And Sexy Fashion Show - See My Smile. See My Style. See My Disability.
Fashion show (25/10/10)hosted by TVs Jonathan Phang and Channel 4s Jon Snow (& including other celebs). To show that people with disabilities can follow fashion, display individuality and have sex appeal. All funds to go to the Jennifer Trust for SMA Read More
Press Release